Glaxo says it has accepted a fine by Chinese courts and added that it has taken steps to change working practices Drugs giant GlaxoSmithKline has been fined A 297 million and a former executive has been handed a prison sentence by the Chinese courts for bribing doctors and hospitals to use its products. Glaxo said it accepted the decision by the Changsha Intermediate People's Court in Hunan province and added that it has already taken steps to change its working practices.